Ask AI
S. 4866

Sickle Cell Disease Treatment Centers Act of 2022

Sickle Cell Disease Treatment Centers Act of 2022

This bill directs the Department of Health and Human Services to award grants for establishing sickle cell disease treatment centers that operate using a hub-and-spoke framework to provide integrated, longitudinal health care for patients with the disease and individuals with sickle cell trait. Grant recipients must be networks comprised of (1) a hospital, clinic, or university health center; (2) at least one federally qualified health center or other health care organization that incorporates community health workers into the care team; and (3) at least one community-based organization.

Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sen. Van Hollen, Chris [D-MD](D-MD)Sponsor
1 cosponsor1 D
1cosponsors1committees2actions2related bills
  1. IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. IntroReferral10000

    Introduced in Senate

Sickle Cell Disease Treatment Centers Act of 2022 — Informed